OH
Opko Health, Inc. disclosed a 29.6% stake in COCP
Opko Health, Inc. reported owning 29.6% of Cocrystal Pharma, Inc. (COCP) (5,692,916 shares) in a Schedule 13D filed Nov 6, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13D